What sectors does Pontifax invest in?

Pontifax focuses on biotech and healthtech.

What investment stages does Pontifax focus on?

Pontifax primarily invests in series-a and series-b stage companies.

What is Pontifax's typical check size?

Pontifax's typical investment is between €3M and €20M.

Where is Pontifax based?

Pontifax is headquartered in Israel.

Pitchkit

Venture capital

Israel

Pontifax

Investment focus

Sectors

Biotech

Healthtech

Investment stages

Series A

Series B

Geographic focus

Global

Israel

United States

Europe

Investment thesis

Israel-based healthcare-dedicated VC with $1.2B under management, investing in breakthrough life sciences innovations at all development stages. Track record of 24 IPOs and 19 acquisitions.

Typical check size

€3M – €20M

Fund size: $1.2B AUM; ~100 portfolio companies; 24 IPOs and 19 acquisitions

Browse similar check sizes →

Portfolio highlights

Kite Pharma - CAR-T cell therapy (acquired by Gilead for $11.9B)

Keros Therapeutics - musculoskeletal and hematologic diseases (NASDAQ-listed)

Mereo BioPharma - rare disease biopharmaceuticals (NASDAQ-listed)

Contact

www.pontifax.com

Israel

Research with AI

Learn more about Pontifax using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what Pontifax and similar investors look for:

Biotech pitch guide Healthtech pitch guide

Ready to start fundraising?

Create your pitch deck with AI, get investor-ready feedback, and find the right investors for your startup.

Get started free

Venture capital

Israel

Pontifax

Investment focus

Sectors

Biotech

Healthtech

Investment stages

Series A

Series B

Geographic focus

Global

Israel

United States

Europe

Investment thesis

Israel-based healthcare-dedicated VC with $1.2B under management, investing in breakthrough life sciences innovations at all development stages. Track record of 24 IPOs and 19 acquisitions.